Johnson & Johnson · JNJ
As of the latest run, Johnson & Johnson (JNJ) scores 33/100 overall — a fragile profile across several dimensions. Its strongest dimension: growth (67/100); the one that most warrants attention: financial health (0/100).
Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.
Growth comes in at 67/100 — sustained revenue growth.
The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.
Financial health falls to 0/100 — a balance sheet under strain, on debt or liquidity. Valuation falls to 17/100 — a stretched price relative to the stock's own valuation history. Profitability falls to 25/100 — thin margins or a disappointing return on capital.
No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.